Howard Marks
Oaktree Capital Management
Howard Marks BeiGene, Ltd stake
total: 853
Oaktree Capital Management ONC trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2019 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2019 Q3
According to 2026 Q2 report, Howard Marks doesn't hold any BeiGene, Ltd (ONC) shares. To date, the estimated cost basis is nearly $123.97 for "buy" trades and estimated average "sell" price is $123.97. Oaktree Capital Management first purchased ONC in 2019 Q2, initially acquiring 26,700 shares. Since the initial investment in BeiGene, Ltd (ONC), Oaktree Capital Management has made 1 more transaction.
When did Howard Marks sell BeiGene, Ltd (ONC)?
Howard Marks sold off the entire BeiGene, Ltd (ONC) position in 2019 Q3.
When did Howard Marks buy BeiGene, Ltd (ONC)?
Howard Marks first invested in BeiGene, Ltd (ONC) in 2019 Q2 at the reported quarter-end price of $123.97 per share.
What's the cost basis of Oaktree Capital Management's ONC stake?
The estimated cost basis for BeiGene, Ltd (ONC) stake is around $123.97 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $123.97
- Weighted AVG sell price:
- $123.97
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.